Free Republic

http://www.npr.org/templates/story/story.php?storyId=4696609 Health & Science Part 1: Documents Suggest Merck Tried to Censor Vioxx Critics by Snigdha Prakash All Things Considered, June 9, 2005 · Because of intense interest in this report, NPR has decided to present a full transcript. Introduction: NPR's story about Merck and its efforts to suppress safety concerns about the painkiller Vioxx continues with a look at how Merck exerted its influence in the world of top medical institutions. NPR's Snighda Prakash presents part two of her report. Transcript: Introduction: At least 38,000 Americans are believed to have died from taking the pain pill Vioxx before it...

The men behind the myth Pharma Salaries. The high cost of research Source: AFL-CIO Executive Paywatch Henry A. McKinnell Chairman and CEO Pfizer Inc. In 2004, Henry A. McKinnell raked in $28,925,241 in totalcompensation including stock option grants from Pfizer Inc.. And Henry A. McKinnell has another $15,096,811 in unexercised stock options from previous years. John C. Martin President and CEO Gilead Sciences In 2004, John C. Martin raked in $18,223,931 in total compensationincluding stock option grants from Gilead Sciences. From previous years' stock option grants, the Gilead Sciences executive cashed out $13,213,769 in stock option exercises. And John C....